Litcius/Paper detail

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies

Daichi Yamasoba, Yusuke Kosugi, Izumi Kimura, Shigeru Fujita, Keiya Uriu, Jumpei Ito, Kei Sato

2022The Lancet Infectious Diseases209 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Monoclonal antibodyCoronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakAntibodySensitivity (control systems)MedicineImmunologyVirusInternal medicineInfectious disease (medical specialty)OutbreakDiseaseEngineeringElectronic engineeringSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesBacillus and Francisella bacterial research